Clinical Trial UCI-17-48


HERO: A Multinational Phase 3, Randomized, Open-label, Parallelgroup Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

Principal Investigator

Edward Uchio


Learn More

For more information about cancer clinical trials at the Chao Family Comprehensive Cancer Center, please call toll-free: 877.UC.STUDY (877.827.8839) or email